Inactive

The Centers for Disease Control and Prevention intends to award a cost reimbursible modification to ABT Associates for COVID-19 Cohort Studies. Abt Associates was awarded (5/1/2020) a contract (75D301... The Centers for Disease Control and Prevention intends to award a cost reimbursible modification to ABT Associates for COVID-19 Cohort Studies. Abt Associates was awarded (5/1/2020) a contract (75D30120C08150; “COVID-19 Cohort Studies”) to adapt multiple existing cohort studies to address critical knowledge gaps essential to inform public health policy decisions for the US response to the COVID-19 pandemic. Prospective cohorts are being conducted with healthcare personnel, first responders, households with children, and older adults. Common protocols and procedures have been finalized and approved by Institutional Review Boards to assess the incidence of symptomatic and asymptomatic SARS-CoV-2 infection using both molecular and serologic diagnostics. Enrollment using random stratified strategies are underway, and consented participants have completed electronic surveys and begun weekly active surveillance for COVID-19 using SMS text and REDCap data management systems that were customized to these cohorts. Methods for self-collection and shipping of respiratory specimens have been developed and approved by major carriers. All specimens are being shipped to a centralized molecular laboratory; specimen management and results reporting systems are implemented. CDC requires the number of participants in these cohorts to be increased in order to examine the effectiveness of licensed COVID-19 vaccines once they become available. Given that the work has already start and because Abt Associates has completed all of the implementation tasks described above, they are the only contractor able to complete this work. It is essential that participants be added to these existing cohorts rather than by initiating new studies in order for data to be comparable and collapsible. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to William Brannen at VWL0@cdc.gov by 10:00 A.M. EST., August 15, 2020.